The rising interest in GLP-1 agonists for diabetes has generated a debate about delivery routes : skin-applied devices versus pills . Usually , GLP-1 therapies were only available in oral form, but the https://antonumaf438206.dsiblogger.com/74028634/glp-1-skin-applications-vs-tablets-is-right-for-you